| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
137.000 |
Evidence |
|
| SH3BP2 |
SH3BP2: Uncharacterized protein SH3BP2 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
137.000 |
Evidence |
|
| CASP2 |
CASP2, ICH1, NEDD2: Caspase-2 precursor |
RIPK1 |
RIPK1, RIP: Receptor-interacting serine/threonine-protein kinase 1 |
137.000 |
Evidence |
|
| VAV1 |
VAV1, VAV: Proto-oncogene vav |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
137.000 |
Evidence |
|
| FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
137.000 |
Evidence |
|
| SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
HGFAC |
HGFAC: Hepatocyte growth factor activator precursor |
137.000 |
Evidence |
|
| PLG |
PLG: Plasminogen precursor |
SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
137.000 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
137.000 |
Evidence |
|
| ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
137.000 |
Evidence |
|
| HAND1 |
HAND1, EHAND: Heart- and neural crest derivatives-expressed protein 1 |
ID3 |
ID3, 1R21, HEIR-1: DNA-binding protein inhibitor ID-3 |
137.000 |
Evidence |
|
| SOCS3 |
SOCS3, CIS3, SSI3: Suppressor of cytokine signaling 3 |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
137.000 |
Evidence |
|
| APS |
SH2B2, APS: SH2B adapter protein 2 |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
137.000 |
Evidence |
|
| NFKBIA |
NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha |
RELB |
RELB: Transcription factor RelB |
137.000 |
Evidence |
O
|
| PROS1 |
PROS1, PROS: Vitamin K-dependent protein S precursor |
F5 |
F5: Coagulation factor V precursor |
136.000 |
Evidence |
|
| LSM1 |
LSM1, CASM: U6 snRNA-associated Sm-like protein LSm1 |
SNRPF |
SNRPF, PBSCF: Small nuclear ribonucleoprotein F |
136.000 |
Evidence |
|
| CDC37 |
CDC37: Hsp90 co-chaperone Cdc37 |
HSP90AA1 |
Hsp89-alpha-delta-N |
136.000 |
Evidence |
O
|
| PLD2 |
PLD2: Phospholipase D2 |
ACTG1 |
ACTB: Actin, cytoplasmic 1 |
136.000 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
135.000 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
JAK1 |
|
135.000 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
135.000 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
135.000 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
BMX |
IPI00514142 |
135.000 |
Evidence |
|
| STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
SYK |
SYK: Tyrosine-protein kinase SYK |
135.000 |
Evidence |
|
| KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
135.000 |
Evidence |
|
| AXL |
AXL, UFO: Tyrosine-protein kinase receptor UFO precursor |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
135.000 |
Evidence |
|